Correction
Published on 02 Jun 2023
Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
in Primary Immunodeficiencies
Frontiers in Immunology
doi 10.3389/fimmu.2023.1226814
- 932 views
Type at least 3 characters
32,274 articles
Original Research
Published on 02 Jun 2023
The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1178355
- 3,272 views
- 4 citations
Original Research
Published on 02 Jun 2023
Identification of diagnostic hub genes related to neutrophils and infiltrating immune cell alterations in idiopathic pulmonary fibrosis
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1078055
- 4,879 views
- 1 citation
Original Research
Published on 02 Jun 2023
Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1070953
- 5,940 views
- 7 citations
Original Research
Published on 02 Jun 2023
Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1119350
- 4,699 views
- 4 citations
Mini Review
Published on 02 Jun 2023
The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1195858
- 5,982 views
- 8 citations
Review
Published on 02 Jun 2023
Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1200195
- 27,003 views
- 44 citations
Mini Review
Published on 02 Jun 2023
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1161849
- 5,013 views
- 9 citations
Original Research
Published on 02 Jun 2023
Pediatric myelin oligodendrocyte glycoprotein antibody-associated disease in southern China: analysis of 93 cases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1162647
- 3,905 views
- 7 citations
Original Research
Published on 02 Jun 2023
Exploration of the impact of multimode thermal therapy versus radiofrequency ablation on CD8+ T effector cells of liver malignancies based on single cell transcriptomics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1172362
- 5,397 views
- 1 citation
Review
Published on 02 Jun 2023
The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1141387
- 5,133 views
- 10 citations
Systematic Review
Published on 02 Jun 2023
Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1180170
- 7,209 views
- 8 citations
Original Research
Published on 02 Jun 2023
The roles of different forms of IL-15 in human melanoma progression
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1183668
- 6,266 views
- 4 citations
Review
Published on 02 Jun 2023
Cathepsins in oral diseases: mechanisms and therapeutic implications
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1203071
- 4,977 views
- 9 citations
Original Research
Published on 02 Jun 2023
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1151194
- 5,424 views
- 8 citations
Original Research
Published on 02 Jun 2023
A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1155637
- 4,282 views
- 3 citations